Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1,2 Cyclohexanediamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109553538B reveals continuous fixed-bed catalysis for high-purity 1 2-cyclohexanediamine. This breakthrough ensures supply chain stability and cost efficiency.
Advanced one-pot synthesis of oxaliplatin via patent CN100540556C. Offers high purity, simplified workflow, and cost reduction in anticancer drug manufacturing.
Patent CN105152831A reveals high-yield asymmetric synthesis. Discover cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115160146B reveals a high-yield one-pot synthesis for 1,2-cyclohexanediamine from cyclohexene oxide, offering significant cost reduction and supply chain stability for global buyers.
Patent CN102731316B reveals a safer sulfonyl protection route for 1,2-N,N'-dimethylcyclohexanediamine, offering high purity and industrial scalability for pharmaceutical supply chains.
Patent CN101723988A details a novel route for high-purity oxaliplatin with minimal silver and oxalic acid residues, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Novel separation method for trans-1-2-cyclohexanediamine via patent CN117417259A. Enhances purity and supply chain efficiency for pharmaceutical intermediate manufacturing.